The Academy of Pharmaceutical Sciences
'Promoting the pharmaceutical sciences'


Teva's patent failure gives long-acting Copaxone generics free rein.....           Neopharma snatches Dr. Reddy's API business as it continues global expansion.....           Can Kadcyla give Roche a softer landing when Herceptin biosims hit? New data could help.....           UnitedHealthcare gives Remicade biosims a leg up with changes to Medicare plans.....           HHS Secretary Azar for attorney general? He?s not interested: WSJ.....           FiercePharmaAsia?China cancer drug discounts; Celltrion?s Rituxan biosim; Otsuka-Proteus digital pill deal.....           AbbVie inks yet another Humira biosim deal?this time with Novartis?as EU launches near.....           Bristol-Myers stumbles in lung cancer quest as I-O star Opdivo flunks small cell trial.....           Johnson & Johnson one-ups Eliquis as Xarelto nabs $1.5B FDA nod in artery disease.....           Merck ditches biosimilar Lantus, but will that ease the path for Mylan?s rival insulin product?.....           Shire opens $1B plant to make rare disease drugs.....           HHS Secretary Azar for attorney general? He?s not interested: WSJ.....           Pharma TV buys so far top last year's $1B spend; AbbVie, Pfizer lead September.....           CDMO Almac adding 100 employees to its North Carolina site.....           Can Sanofi's new long-term Lemtrada data amp up sales in a crowded MS field?.....           Investor suits against AbbVie pile up in wake of Humira kickback allegations.....           Got tech ideas for diabetes? Novo wants you for its crowdsourcing challenge.....           FDA panel unanimously backs Celltrion's Rituxan biosimilar.....           Novartis' Gilenya tops Teva giant Copaxone in head-to-head MS study.....           Novartis, Pfizer, AZ and more hand China 50%-plus cancer drug discounts.....           Teva has buyer for plant in Israel that could save 200 jobs: report.....           Roche bolsters MS blockbuster Ocrevus with new long-term disability data.....           Lilly, Merck and Pfizer lead pharma's share price gains through 9 months: report.....           Allergan works toward blockbuster goal with new jawline approval for CoolSculpting.....           Can Big Pharma's moneymakers stay hot as price hikes slow down?.....           FDA panel unanimously backs Celltrion's Rituxan biosimilar.....           Roche?s Kadcyla reduces disease recurrence risk in breast cancer study.....           PCI completes new facility for clinical trial returns in UK.....           HiFiBiO Therapeutics buys early-stage biotech firm H-Immune Therapeutics.....           Alliqua BioMedical, Adynxx enter into merger deal.....           Dr. Reddy?s to sell API manufacturing business unit in Hyderabad, India.....           MaaT Pharma doses first patient in phase 2 trial of biotherapeutic to treat acute GvHD.....           Mereo completes patient enrollment for brittle bone disease trial.....           Merck KGaA debuts original songs to spotlight male infertility and fight stigma against women.....           FDA reviewers endorse Celltrion's Rituxan biosimilar ahead of panel vote.....           Litigation teaches Chinese valsartan maker the downside of U.S. market.....           Celgene notches positive Otezla data in scalp psoriasis as it guns for market expansion.....           Stada, eyeing OTC expansion, circles Bristol-Myers? French Upsa business: report.....           Focusing on OTC, Perrigo swaps CEOs and names former tobacco executive Kessler to the post.....           Pfizer poaches Quest executive to spearhead digital, but the rest of Bourla's supporting cast looks familiar.....           Biotech that bought GlaxoSmithKline's 'bubble boy' drug is building stem cell manufacturing facility in U.S......           See, snap and fund: Johnson & Johnson Vision push for eye health to donate to charity for shared photos.....           With nod in older adults, Merck drives HPV shot Gardasil 9 into big new market.....           GlaxoSmithKline taps Publicis?and its 'platformGSK' setup?for $1.5B media account.....           Merck snags national VA contract for its Remicade biosimilar thanks to discount pricing offer.....           Biogen's new Spinraza data for earlier use 'pretty amazing,' analyst says.....           Biotech that bought GSK's 'bubble boy' drug to build stem cell manufacturing facility in U.S......           RSS NEWSFEED....
Welcome to
The Academy of
Pharmaceutical Sciences
 
The Academy of Pharmaceutical Sciences (APS) is the UK-based professional membership body for Pharmaceutical Scientists.

We represent individuals and organisations from around the globe, throughout their development, in the delivery of excellence in the Pharmaceutical Science sector.
 
 
 
 
Latest news

Professional recognition for Pharmaceutical Science Degrees

The Academy of Pharmaceutical Sciences (APS) is delighted to announce that the pharmaceutical science course at the University of Greenwich has become the first APS accredited course having successfully completed the accreditation process set up by the Academy towards the end of 2017.

This is the first time that a pharmaceutical science course has been accredited in the United Kingdom and it is also, we believe, a world first.

Achieving accreditation gives assurance to students and employers that the course meets the high standards required by the Academy and that these standards will be maintained throughout the 5-year period of accreditation.

APS believes that the accreditation process will raise the profile of pharmaceutical sciences in both academia and industry. The discipline is key in the discovery, development and manufacture of new medicines and as such is central to government initiatives to encourage the pharmaceutical industry to maintain and strengthen its strong base here in the UK.

The Academy will continue to work with other stakeholders to build the science base for the ultimate benefit of patients.

 
 
APS events overview

The APS is developing an exciting and informative programme of events in 2019.

Please take a look at our programme here.

OTHER EVENTS IN DEVELOPMENT
Developability for Biologicals
Inhaled Workshop
Basic Biopharmaceutics workshop 

Follow us
 
Upcoming Events
8th Annual MIBio Conference
15 November 2018
APS Additive Manufacturing Symposium
27 March 2019
APS Developability Workshop
17 - 18 April 2019
APS Industrial Insights 2019
25 - 26 April 2019
10th APS International PharmSci conference 2019
11 - 13 September 2019
Job Vacancies
View all Vacancies
Advertise your job vacancies
The APS is grateful for the support of:
Join Us

Join the academy and get discounts on events, post-nominals, latest news and more.

 

The Academy of Pharmaceutical Sciences
Unit Q, Troon Way Business Centre
Humberstone Lane, Leicester, LE4 9HA
Tel: 0116 274 7351, Fax: 0116 274 7365, Email: info@apsgb.org

Terms of use:
The material included on this site is provided for information purposes only, and we make no representations or warranties as to its accuracy. Before relying on this material, you should take care to verify its accuracy, taking professional advice as appropriate.

Privacy Policy:
For details on the data we collect and how we store and process your data please refer to our Privacy Policy.